Evogene (EVGN)
NASDAQ:EVGN
Want to see EVGN full AI Analyst Report?
Total Valuation
Evogene has a market cap or net worth of $8.53M. The enterprise value is -$490.53K.
Market Cap$8.53M
Enterprise Value-$490.53K
Share Statistics
Evogene has 12,103,764 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,103,764
Owned by Insiders―
Owned by Institutions3.85%
Financial Efficiency
Evogene’s return on equity (ROE) is 103.48 and return on invested capital (ROIC) is -81.04%.
Return on Equity (ROE)103.48
Return on Assets (ROA)-0.42
Return on Invested Capital (ROIC)-81.04%
Return on Capital Employed (ROCE)-0.85
Revenue Per Employee32.93K
Profits Per Employee-121.00K
Employee Count117
Asset Turnover0.19
Inventory Turnover19.50
Valuation Ratios
The current PE Ratio of Evogene is ―. Evogene’s PEG ratio is 0.02.
PE Ratio―
PS Ratio2.25
PB Ratio-105.63
Price to Fair Value-105.63
Price to FCF-0.64
Price to Operating Cash Flow-0.58
PEG Ratio0.02
Income Statement
In the last 12 months, Evogene had revenue of 3.85M and earned -8.48M in profits. Earnings per share was -1.08.
Revenue3.85M
Gross Profit-241.00K
Operating Income-14.03M
Pretax Income-13.50M
Net Income-8.48M
EBITDA-12.20M
Earnings Per Share (EPS)-1.08
Cash Flow
In the last 12 months, operating cash flow was -12.06M and capital expenditures -23.59K, giving a free cash flow of -12.08M billion.
Operating Cash Flow-12.06M
Free Cash Flow-12.08M
Free Cash Flow per Share-1.00
Dividends & Yields
Evogene pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.53
52-Week Price Change-35.32%
50-Day Moving Average0.78
200-Day Moving Average1.03
Relative Strength Index (RSI)40.04
Average Volume (3m)115.16K
Important Dates
Evogene upcoming earnings date is Aug 26, 2026, TBA (Confirmed).
Last Earnings DateMay 20, 2026
Next Earnings DateAug 26, 2026
Ex-Dividend Date―
Financial Position
Evogene as a current ratio of 4.38, with Debt / Equity ratio of -79.80%
Current Ratio4.38
Quick Ratio4.32
Debt to Market Cap0.00
Net Debt to EBITDA0.88
Interest Coverage Ratio-7.42
Taxes
In the past 12 months, Evogene has paid 1.00K in taxes.
Income Tax1.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Evogene EV to EBITDA ratio is 0.17, with an EV/FCF ratio of 0.15.
EV to Sales-0.54
EV to EBITDA0.17
EV to Free Cash Flow0.15
EV to Operating Cash Flow0.16
Balance Sheet
Evogene has $13.09M in cash and marketable securities with $2.03M in debt, giving a net cash position of $11.05M billion.
Cash & Marketable Securities$13.09M
Total Debt$2.03M
Net Cash$11.05M
Net Cash Per Share$0.91
Tangible Book Value Per Share$1.91
Margins
Gross margin is 30.93%, with operating margin of -364.24%, and net profit margin of -220.22%.
Gross Margin30.93%
Operating Margin-364.24%
Pretax Margin-350.32%
Net Profit Margin-220.22%
EBITDA Margin-316.56%
EBIT Margin-346.25%
Analyst Forecast
The average price target for Evogene is $2.15, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$2.15
Price Target Upside95.45% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-72.74%
EPS Growth Forecast48.64%